Watchdog warns of illegal weight loss medicines
Soaring demand for GLP-1 receptor agonists, commonly prescribed for diabetes and obesity, is driving a surge in the online sale of illegal medicines. The European Medicines Agency (EMA) […]
Soaring demand for GLP-1 receptor agonists, commonly prescribed for diabetes and obesity, is driving a surge in the online sale of illegal medicines. The European Medicines Agency (EMA) […]
In an analysis by race, sex, age, and geography, alcohol-induced death rates in 2024 are nearly double those in 1999, with a sharp increase at the onset of the […]
A systematic review by Isobel Blanksby and Holly Carding found that menopausal symptoms had a significant impact on the well-being and productivity of NHS staff. Given that women […]
GLP-1 receptor agonist drugs protect against diabetic retinopathy, a common complication of diabetes that can lead to sight loss, suggests new research being presented at the annual meeting […]
The provision of accessible and specialised menopause care within the National Health Service (NHS) has historically faced significant challenges, often leaving patients to navigate long waits or resort […]
The guideline was developed in line with internationally recognised standards, including the GRADE methodology and the RIGHT reporting statement, and reflects the EASD’s newly established Standard Operating Procedures […]
An Indiana University study brings a comprehensive new perspective to a growing body of evidence suggesting that mild to moderate use of prescribed opioid pain medications during pregnancy […]
The new class of anti-obesity drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), is proving remarkably effective at helping individuals lose weight. However, a new population-wide study being presented at […]
Medications taken years ago can continue to shape the human gut microbiome, according to a large-scale study from the University of Tartu Institute of Genomics. Analysing stool samples […]
Researchers report that patients with psoriasis treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) have achieved a 78% reduced risk of death and a 44% reduced risk of major […]
Women taking popular weight-loss medications during their reproductive years may be unaware of associated risks to pregnancy and unborn babies, warn Flinders University researchers. A new study has […]
Researchers from Children’s Hospital of Philadelphia (CHOP) and Mass General Brigham found that integrating an automated smoking cessation intervention for parents into pediatric primary care demonstrated increased treatment […]
ADVERTISMENT